iBio
IBIO
#10074
Rank
HK$0.21 B
Marketcap
HK$9.34
Share price
-6.25%
Change (1 day)
-53.65%
Change (1 year)

iBio (IBIO) - Net assets

Net assets on the balance sheet as of June 2025 : HK$0.11 Billion

According to iBio's latest financial reports the company has HK$0.11 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

iBio - Net assets on balance sheet (from 2008 to 2025)

Net assets by year

Year Net assets Change
2024-06-30$HK$0.16 B38.16%
2023-06-30$HK$0.12 B-75.81%
2022-06-30$HK$0.49 B-40.9%
2021-06-30$HK$0.84 B92.13%
2020-06-30$HK$0.43 B2185.82%
2019-06-30$HK$19.19 M-84.87%
2018-06-30$HK$0.12 B82.28%
2017-06-30$HK$69.59 M-62.7%
2016-06-30$HK$0.18 B114.32%
2015-06-30$HK$87.05 M84.17%
2014-06-30$HK$47.26 M20.25%
2013-06-30$HK$39.3 M-17.87%
2012-06-30$HK$47.85 M3027.22%
2011-06-30$HK$1.53 M-81.74%
2010-06-30$HK$8.38 M-75.35%
2009-06-30$HK$34 M-170.32%
2008-06-30$-HK$48.37 Million42.8%
2007-06-30$-HK$33.87 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Genocea Biosciences
GNCA
HK$96.41 M-16.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$4.53 B 3,814.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$617.13 B 532,675.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
HK$0.66 B 471.81%๐Ÿ‡บ๐Ÿ‡ธ USA